Tools

LEADER 04766cam a22006257i 4500

001 ssj0001468602;

003 WaSeSS;

005 20220112082112.0;

006 m d ;

007 cr n ;

008 150629t20142014dcuab sb f100 0 eng d;

010 a| 2015304840;

020 a| 9780309312707;

020 a| 0309312701;

035 a| (WaSeSS)ssj0001468602;

042 a| lccopycat;

043 a| n-us---;

049 a| EREEa| NEHH;

050 00 a| RA410.53b| .E568 2014;

082 04 a| 338.43362109732| 23;

111 2 a| Ensuring Patient Access to Affordable Cancer Drugs (Workshop)d| (2014 :c| Washington, D.C.)?| UNAUTHORIZED;

245 10 a| Ensuring patient access to affordable cancer drugsh| [electronic resource] :b| workshop summary /c| Sharyl J. Nass and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.;

260 a| Washington, D.C. :b| The National Academies Press,c| [2014];

300 a| xx, 54 pages :b| illustrations (some color), map (color) ;c| 23 cm.;

504 a| Includes bibliographical references (pages 47-49).;

505 0 a| Introduction -- new landscape of cancer care -- High out-of-pocket expenses -- Migration of private practices to hospitals -- Factors influencing cancer care access and costs -- Drug shortages -- Reimbursement constraints and incentives -- 340B -- Consolidation of practices -- Potential solutions -- Patient incentives -- Physician incentives --Drug manufacturer incentives -- Wrap-up.;

506 a| Available only to authorized users.;

520 a| "In recent years, patients' out-of-pocket costs for cancer care have been rising rapidly. These costs include health insurance deductibles, coinsurance, and copayments for covered services, as well as services that are not covered by insurance. Many cancer patients are especially vulnerable financially because their illness and/or treatment impedes their ability to work, with some patients losing employment altogether. Even with insurance, cancer patients often experience financial hardships, such as going into debt, depleting all assets to pay for cancer treatment, and personal bankruptcy. Although many elements contribute to the cost of cancer care, one important component is the cost of new cancer drugs, which has been escalating rapidly in recent years. To explore the issue of cancer drug costs and patient access to affordable, appropriate drug therapies, the Institute of Medicine's National Cancer Policy Forum convened a workshop on ensuring patient access to affordable cancer drugs in June 2014. Affordability was considered from both individual and societal perspectives. The workshop featured discussion panels as well as invited presentations from clinicians, researchers, representatives from the health insurance and pharmaceutical industries, and patient advocates. Ensuring Patient Access to Affordable Cancer Drugs summarizes the presentation and discussion of the workshop."--c| Source other than Library of Congress.;

530 a| Also available via the World Wide Web.;

538 a| Mode of access: World Wide Web;

650 0 a| Cancerx| Treatmentx| Costs.=| ^A13628;

650 0 a| Antineoplastic agentsx| Costs.=| ^A1221;

650 0 a| Drugsx| Costs.=| ^A640;

650 0 a| Medical care, Cost ofz| United States.=| ^A4211;

650 0 a| Health services accessibilityz| United States.=| ^A9783;

650 12 a| Antineoplastic Agentsx| economicsz| United States.=| ^A1336017;

650 12 a| Fees, Pharmaceuticalz| United States.=| ^A919449;

650 22 a| Drug Costsz| United States.=| ^A1004885;

650 22 a| Health Services Accessibilityz| United States.=| ^A919538;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Nass, Sharyl J.=| ^A875025;

700 1 a| Patlak, Margie.=| ^A1015055;

710 2 a| National Cancer Policy Forum (U.S.)=| ^A876199;

710 2 a| Institute of Medicine (U.S.).b| Board on Health Care Services,b| sponsoring body.?| UNAUTHORIZED;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=3379406;

947 a| (OCoLC)ocn899248575;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 5564521;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5564521-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 2/19/2021x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5564521-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 2/19/2021x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5564521-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 2/19/2021x| EBOOKz| JERESOURCE;

Ensuring patient access to affordable cancer drugs workshop summary / Sharyl J. Nass and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.

Author/creator	Ensuring Patient Access to Affordable Cancer Drugs (Workshop)
Format	Electronic
Publication Info	Washington, D.C. : The National Academies Press, [2014]
Description	xx, 54 pages : illustrations (some color), map (color) ; 23 cm.
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	Cancer--Treatment. --Costs. Antineoplastic agents--Costs. Drugs--Costs. Medical care, Cost of--United States. Health services accessibility--United States. Antineoplastic Agents--economics. --United States. Fees, Pharmaceutical--United States. Drug Costs--United States. Health Services Accessibility--United States.

Other author/creator	Nass, Sharyl J.
Other author/creator	Patlak, Margie.
Other author/creator	National Cancer Policy Forum (U.S.)
Other author/creator	Institute of Medicine (U.S.). Board on Health Care Services, sponsoring body.
Contents	Introduction -- new landscape of cancer care -- High out-of-pocket expenses -- Migration of private practices to hospitals -- Factors influencing cancer care access and costs -- Drug shortages -- Reimbursement constraints and incentives -- 340B -- Consolidation of practices -- Potential solutions -- Patient incentives -- Physician incentives --Drug manufacturer incentives -- Wrap-up.
Abstract	"In recent years, patients' out-of-pocket costs for cancer care have been rising rapidly. These costs include health insurance deductibles, coinsurance, and copayments for covered services, as well as services that are not covered by insurance. Many cancer patients are especially vulnerable financially because their illness and/or treatment impedes their ability to work, with some patients losing employment altogether. Even with insurance, cancer patients often experience financial hardships, such as going into debt, depleting all assets to pay for cancer treatment, and personal bankruptcy. Although many elements contribute to the cost of cancer care, one important component is the cost of new cancer drugs, which has been escalating rapidly in recent years. To explore the issue of cancer drug costs and patient access to affordable, appropriate drug therapies, the Institute of Medicine's National Cancer Policy Forum convened a workshop on ensuring patient access to affordable cancer drugs in June 2014. Affordability was considered from both individual and societal perspectives. The workshop featured discussion panels as well as invited presentations from clinicians, researchers, representatives from the health insurance and pharmaceutical industries, and patient advocates. Ensuring Patient Access to Affordable Cancer Drugs summarizes the presentation and discussion of the workshop."-- Source other than Library of Congress.
Bibliography note	Includes bibliographical references (pages 47-49).
Access restriction	Available only to authorized users.
Other forms	Also available via the World Wide Web.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2015304840
ISBN	9780309312707
ISBN	0309312701

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Ensuring patient access to affordable cancer drugs workshop summary / Sharyl J. Nass and Margie Patlak, rapporteurs ; National Cancer Policy Forum, Board on Health Care Services, Institute of Medicine of the National Academies.

Click here for more information about this title

Availability